Assignee
OYSTER POINT PHARMA INC
US·19 granted patents·13 pending applications·112 citations·filing 2015–2025
Top patents by PatentIndex Score
32 records- 0198US11542253B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2021·Granted Jan 3, 2023·6 cites·10 claims
- 0297US10919879B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2019·Granted Feb 16, 2021·7 cites·9 claims
- 0396US11911380B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2023·Granted Feb 27, 2024·2 cites·30 claims
- 0496US11903941B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2021·Granted Feb 20, 2024·2 cites·24 claims
- 0596US11903943B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2023·Granted Feb 20, 2024·2 cites·30 claims
- 0696US11224598B2Methods of increasing lacrimal proteinsOYSTER POINT PHARMA INC·Filed 2019·Granted Jan 18, 2022·6 cites·19 claims
- 0796US10421745B2Salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2018·Granted Sep 24, 2019·10 cites·14 claims
- 0895US11903942B2Compositions and use of varenicline for treating dry eyeOYSTER POINT PHARMA INC·Filed 2023·Granted Feb 20, 2024·1 cites·30 claims
- 0995US9981949B2Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2016·Granted May 29, 2018·8 cites·14 claims
- 1094US10456396B2Dry eye treatmentsOYSTER POINT PHARMA INC·Filed 2017·Granted Oct 29, 2019·9 cites·100 claims
- 1194US9597284B2Dry eye treatmentsOYSTER POINT PHARMA INC·Filed 2015·Granted Mar 21, 2017·11 cites·15 claims
- 1294US9532944B2Methods of improving ocular discomfortOYSTER POINT PHARMA INC·Filed 2015·Granted Jan 3, 2017·12 cites·15 claims
- 1394US9504644B2Methods of increasing tear productionOYSTER POINT PHARMA INC·Filed 2015·Granted Nov 29, 2016·11 cites·15 claims
- 1494US9504645B2Pharmaceutical formulations for treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2015·Granted Nov 29, 2016·10 cites·13 claims
- 1591US12098018B2Nesting structures for storage, transport, and assembly of drug dispensers and containersOYSTER POINT PHARMA INC·Filed 2021·Granted Sep 24, 2024·6 cites·9 claims
- 1691US2024246936A1Synthesis and novel salt forms of (r)-5-((e)-2-(pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2024·Application pending·0 cites
- 1790US10709707B2Methods of treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2017·Granted Jul 14, 2020·7 cites·72 claims
- 1890US2024173318A1Dry eye treatmentsOYSTER POINT PHARMA INC·Filed 2024·Application pending·0 cites
- 1984US12576080B2Use of varenicline for treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2025·Granted Mar 17, 2026·0 cites·29 claims
- 2083US2023295126A1Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3-ylvinyl)pyrimidineOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 2182US2025000861A1Methods of treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2024·Application pending·0 cites
- 2264US2025352668A1Aav vector encoding diamine oxidase and uses thereofOYSTER POINT PHARMA INC·Filed 2023·Application pending·0 cites
- 2362US2020345734A1Methods of treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2020·Application pending·0 cites
- 2459USD1055276SNasal spray guideOYSTER POINT PHARMA INC·Filed 2022·Granted Dec 24, 2024·2 cites·1 claims
- 2559US2024238375A1Aav virion encoding neurotrophic factor and uses thereofOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 2658US2023210861A1Local administration of nicotinic acetylcholine receptor agonists for the inhibition of coronavirus infectionsOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 2758US2026083637A1Dispenser configured for aseptic transfer of a liquid productOYSTER POINT PHARMA INC·Filed 2023·Application pending·0 cites
- 2856US2024226109A1Co-therapy with vector and nicotinic agonistOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 2954US2023381800A1Nasal spray guideOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 3053US2024058216A1Dispenser configured for aseptic transfer of a liquid productOYSTER POINT PHARMA INC·Filed 2022·Application pending·0 cites
- 3147US2021379066A1Combinations of positive allosteric modulators and nicotinic acetylcholine receptor agonists for treating ocular conditionsOYSTER POINT PHARMA INC·Filed 2021·Application pending·0 cites
- 3234USD1055277SNasal spray guideOYSTER POINT PHARMA INC·Filed 2022·Granted Dec 24, 2024·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when OYSTER POINT PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →